Mayo Clinic has sold mRemedy, a company formed by Mayo and DoApp Inc. that offers a mobile healthcare platform to providers, to Axial Exchange, a Raleigh, N.C.-based virtual software-as-a-service company. The platform, myTality, aims to help patients navigate future hospital visits, and help hospitals better market their services. Axial plans on using it in conjunction with its care-transition platforms, Axial Patient and Axial Provider.
The deal, brokered by Axial’s lead venture capital investor Canaan Partners, provides the vendor with with access to consumer content from MayoClinic.com, which offers patients various general healthcare related information, including stuff on nearly 1,000 conditions and diseases.
In addition, four Mayo Clinic physicians will join Axial’s Advisory Board including Paul Y. Takahashi, M.D.; Nathan Jacobson, D.O., and two others to be named.
“Patients and their families want and expect the most up-to-date information about life, health, disease and treatment,” Dr. Paul Takahashi, associate professor of medicine at Mayo Clinic, said in a statement. “Mayo Clinic’s health information content will now reach even more people, providing accurate answers to common and uncommon health issues.”
The Bill and Melinda Gates Foundation is awarding $210 million to Seattle-based University of Washington’s Population Health Initiative, with the funds going toward the construction of a new building to serve as the initiative’s hub.
More than half (56 percent) of healthcare professionals believe their organization could be doing more to educate employees on HIPAA compliance and the rules around sharing protected health information.
The Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai is partnering with DigitalGlobe to create the Health Equity Atlas Initiative (ATLAS), a platform that standardizes and maps population data in order to generate insights that address health inequities.